| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |